Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
Date:2/22/2010

ost of revenues 99,673 (19,339) (1) 80,334 Selling, general and administrative 145,003 - 145,003 Research and development 48,705 (15,979) (2) 32,726 Impairment of intangibles 69,000 (69,000) (3) - Acquisition-related items (134,303) 134,303 (4) - Operating income 163,328 (29,985) 133,343 Interest (income) expense, net 9,505 (4,020) (5) 5,485 Other (income) expense, net (1,725) 1,555 (6) (170) Income before income taxes 155,548 (27,520) 128,028 Income taxes 7,700 25,181 (7) 32,881 Net income $147,848 $(52,701) $95,147 Diluted earnings per share $1.25 $0.81 Diluted weighted average shares 117,859 117,859 Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations: (1) To exclude amortization of commercial intangible assets related to marketed products of $19,217 and the impact of an Indevus inventory step-up recorded as part of acquisition accounting of $122. (2) To exclude upfront and milestone payments to partners. (3) To exclude the impairment of AVEED and PRO2000 for $65,000 and $4,000, respectively. (4) To exclude Indevus transaction and separation cost reversals of ($2,973) as well as the impact, under purchase accounting, of a gain recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisitio
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  Hill-Rom Holdings, Inc. (NYSE: ... management presentation at the Morgan Stanley Global Healthcare Conference ... You are invited to listen to the live ... or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A ... hour after conclusion of the live event and accessible ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... new market research report is available ... Chinese Guidebook for Application and Approval ... Regulations to Practices (2014 Edition) ... Now, Chinese regulations ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... , NEW YORK, Nov. 20 ... report is available in its catalogue. , ... , http://www.reportlinker.com/p0164373/Pipettes--Pipettors---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... part of any research laboratory. Large-scale applications in ...
... , NATICK, Mass. and LONDON, ... BSX ) today announced that it has received 510(k) ... and CE Mark approval to market its WallFlex® Fully ... strictures (obstructions) caused by tumors in patients with resectable ...
Cached Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4
(Date:8/28/2014)... 28, 2014 Tea Leaves Health ... Gigya, the leader in Connected Consumer Management. By ... will have the opportunity to build more authentic ... they are and how they like to interact. ... world’s biggest brands to understand and connect with ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 Now in ... run/walk that was started in 2011 by two brain aneurysm ... raise much needed awareness, provide education to help increase early ... been impacted by a brain aneurysm. We hope that you ... a worthy cause at the 4th Annual Step for Hope ...
(Date:8/28/2014)... Houston, Texas (PRWEB) August 28, 2014 ... Program. The program is a chance for regular customers ... MMAR Medical without the need for a wholesale license. ... athletics coaches, semi-professional athletic programs and others who regularly ... point. , “Whether supporting your own active lifestyle ...
(Date:8/28/2014)... The revenue cycle process touches on nearly everything ... patient books an appointment with a physician’s office, until ... services rendered to the healthcare provider. Medorizon ... RCM process down to a science. Over the past ... in nearly every healthcare facility around the globe. While ...
(Date:8/28/2014)... 2014 UniVoIP, Inc, a managed ... today announced that they have been certified with the ... Local Small Business Enterprise (Local SBE) Preference Programs. “We ... the state of California and LA county and excited ... Solution to governmental agencies throughout the state,“ says ...
Breaking Medicine News(10 mins):Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:MMAR Medical Announces Customer Membership Program 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Cloud PBX Provider UniVoIP Gets Certified by the State of California and the County of Los Angeles Under the Local Small Business Enterprise (SBE) Preference Program 2
... Oct. 26 Paramount Acquisition Corp.,(OTC Bulletin Board: PMQC, ... of 100% of the outstanding stock of B.J.K.,Inc., a ... Rx"),pursuant to a Stock Purchase Agreement, by and among ... June 1, 2007, as amended. Effective as,of the closing ...
... Genta,Incorporated (Nasdaq: GNTA ) announced today ... the Company,s Board of Directors. Dr.,McCaughey has served ... noted author and health policy expert, we appreciate ... infections from,multiply resistant organisms, along with her increasing ...
... Donations of more than $1 million worth of prescription medicines and ... ... GlaxoSmithKline,(NYSE: GSK ) shares the nation,s concern for residents and ... fires.,As a demonstration of support, GSK has offered to the people ...
... at Buffalo,s Research Institute on Addictions (RIA) is initiating ... used in behavioral medicine for stress reduction but not ... use disorders. , ... MBSR in alcoholism treatment, we hope to develop an ...
... proprietary ... technology-, MADISON, ... nation,s leading provider of diagnostic,testing, information and services, announced today that ... tracking technology,underlying Pathway Diagnostics, SensiTrop(TM) HIV co-receptor tropism test.,Tropism refers to ...
... PRAIRIE, Minn., Oct. 26 Most people learn about,long term care the ... that is when they find out that: -- Long term care ... health insurance, disability or HMO plan; and ... you have very limited income and assets. Even ...
Cached Medicine News:Health News:Paramount Completes Acquisition of Chem Rx 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 3Health News:GlaxoSmithKline Aids California Fire Relief Efforts 2Health News:Dealing with stress as a treatment for alcohol abuse 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 2Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 3Health News:Quest Diagnostics Licenses Technology Underlying SensiTrop(TM) HIV Co-Receptor Tropism Test from Pathway Diagnostics 4Health News:Congress Declares 'Long Term Care Awareness Week' - Long Term Care Group, Inc. Continues Related Work 2
Quick Release Holder designed for the 8000 Series Microtome to hold hardboard squares....
... rotary retracting, self-lubricating design and has a heavy ... construction makes it accurate and incredibly reliable. ,The ... lateral motion is controlled and allows no slop ... lesser designs which can result in 'chatter' and ...
Allows for custom orientation of specimen...
Disposable Feather Blades, 50 per pack...
Medicine Products: